TRAVIS H NAKAMURA

Allopathic & Osteopathic Physicians|Internal Medicine HONOLULU, HI NPI 1669560306

General Payments — all program years on this page

$2,952.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 164
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $302.23 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $302.2313

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $152.956
Novo Nordisk AS $125.846
Lilly USA, LLC $23.441

By program year

Program yearAmountRecords
2018 $357.6021
2019 $360.0519
2020 $654.3736
2021 $597.9540
2022 $399.0222
2023 $280.8613
2024 $302.2313

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096638069 Novo Nordisk Inc $19.91 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096763133 Novo Nordisk Inc $19.46 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096869566 Novo Nordisk Inc $27.70 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096956870 Novo Nordisk Inc $20.08 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097582622 Novo Nordisk Inc $18.56 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097685527 Novo Nordisk Inc $20.13 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104536011 AstraZeneca Pharmaceuticals LP $24.43 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104713569 AstraZeneca Pharmaceuticals LP $24.99 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105207197 AstraZeneca Pharmaceuticals LP $24.82 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105261962 AstraZeneca Pharmaceuticals LP $29.07 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105539987 AstraZeneca Pharmaceuticals LP $29.07 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105899426 AstraZeneca Pharmaceuticals LP $20.57 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135450936 Lilly USA, LLC $23.44 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.